ultraview universal hrp multimer (Roche)
Roche manufactures this product 
86
Structured Review
Roche
ultraview universal hrp multimer
Ultraview Universal Hrp Multimer, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ultraview+hrp+universal+multimer/pmc10317985-246-52-56
Average 86 stars, based on 1 article reviews
Ultraview Universal Hrp Multimer, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ultraview+hrp+universal+multimer/pmc10317985-246-52-56
Average 86 stars, based on 1 article reviews
ultraview universal hrp multimer - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Incubation:Article Title: The expression and prognostic relevance of CDH3 in tongue squamous cell carcinoma. Article Snippet: Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland; Department of Pathology, University of Tampere, Tampere, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Otorhinolaryngology, Tampere University Hospital, Tampere, Finland; Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland; Medical Research Centre, Oulu University Hospital, Oulu, Finland; Helsinki University Hospital, Helsinki, Finland; Research Programs Unit, Genome-Scale Biology, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden; Applied Tumor Genomics Research Program, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland; Department of Pathology, University of Helsinki and HUSLAB, Helsinki, Finland; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, HUS Helsinki University Hospital, Helsinki, Finland; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Department of OtorhinolaryngologyHead and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Pathology, Fimlab Laboratories and Department of Medicine and Health Technology, Tampere University, Tampere, Finland; and Skin and Allergy Hospital, Helsinki University Hospital, Haartman Institute University of Helsinki, University of Helsinki, Helsinki, Finland |